- Trials with a EudraCT protocol (12)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
12 result(s) found for: Schober's test.
Displaying page 1 of 1.
EudraCT Number: 2014-003040-12 | Sponsor Protocol Number: TZSA2 | Start Date*: 2014-10-02 | |||||||||||
Sponsor Name:MDM S.p.A. | |||||||||||||
Full Title: A phase III, multicenter, randomized, parallel groups study to assess the efficacy and safety of 0,5 mg Tizaspray® administered intranasally versus Sirdalud® 2 mg tablets, in patients with acute lo... | |||||||||||||
Medical condition: Acute low back pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-007694-23 | Sponsor Protocol Number: 593 | Start Date*: 2008-07-28 |
Sponsor Name:Forschergruppe Diabetes e. V. | ||
Full Title: Transfusion of Autologous Umbilical Cord Blood to Reverse Hyperglycemia in Children with Type 1 Diabetes - A Pilot Study | ||
Medical condition: Type 1 Diabetes | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2007-000634-39 | Sponsor Protocol Number: 808040006 | Start Date*: 2007-09-03 |
Sponsor Name:Forschergruppe Diabetes e. V. am Helmholtz Zentrum München | ||
Full Title: Postpartum Intervention in Women with Gestational Diabetes using Insulin | ||
Medical condition: women with a recent history of gestational diabetes which required insulin therapy up to 7 months post-partum | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-000787-90 | Sponsor Protocol Number: 2005-000787-90 | Start Date*: 2005-09-27 |
Sponsor Name:Hellmuth Ulrici Kliniken | ||
Full Title: Wirksamkeit periduraler Steroidinjektionen im Rahmen eines multimodelen Behandlungskonzeptes in der Therapie von nicht radikulären chronischen Rückenschmerzen | ||
Medical condition: Patienten mit chronischen lumbalen, nicht radikulären Schmerzsyndromen bei vorhandenen lumbalen Bandscheibenschaden | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002085-31 | Sponsor Protocol Number: RAD-ON02 | Start Date*: 2017-11-14 |
Sponsor Name:Kurort Forschungsverein Bad Steben e.V. | ||
Full Title: Determining the immunological and pain reducing effects of serial radon balneology in patients with musculoskeletal disorders. | ||
Medical condition: Chronic degenerative spine and/or joint disorders with pain perception of at least 1 year and pain intensity on visual analogue scale ≥4 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2022-000724-37 | Sponsor Protocol Number: EP-DIC-TIO/75+4-F-01-2022 | Start Date*: 2022-11-08 | ||||||||||||||||
Sponsor Name:EPIFARMA S.R.L. | ||||||||||||||||||
Full Title: Randomized, double-blind, parallel-groups, active - and placebo-controlled study to Evaluate the efficacy of a fixed combination of diclofenac 75 mg + thiocolchicoside 4 mg as solution for injectio... | ||||||||||||||||||
Medical condition: Low back pain (LBP) is one of the most frequent and disabling health problems. It is estimated that about 80% of adults will experience an episode of acute or chronic LBP at least once during their... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Trial now transitioned) GR (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004915-22 | Sponsor Protocol Number: A3921145 | Start Date*: 2012-08-03 | |||||||||||
Sponsor Name:Pfizer Inc, 235 East 42nd Street, New York, New York 10017 | |||||||||||||
Full Title: A LONG-TERM, OPEN-LABEL FOLLOW-UP STUDY OF CP-690,550 FOR TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS (JIA) | |||||||||||||
Medical condition: JUVENILE IDIOPATHIC ARTHRITIS (JIA) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) PL (Trial now transitioned) DE (Completed) SK (Completed) IT (Completed) ES (Ongoing) GB (GB - no longer in EU/EEA) BE (Trial now transitioned) NL (Prematurely Ended) SE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-012520-84 | Sponsor Protocol Number: 0881A1-3338 | Start Date*: 2009-08-19 | |||||||||||
Sponsor Name:Wyeth Research Division of Wyeth Pharmaceuticals Inc., Clinical Research and Development | |||||||||||||
Full Title: A 2-Part Open-label Study to Assess the Clinical Benefit and Long-term Safety of Etanercept in Children and Adolescents With Extended Oligoarticular Juvenile Idiopathic Arthritis, Enthesitis-Relate... | |||||||||||||
Medical condition: Extended oligoarticular juvenile idiopathic arthritis (JIA) Enthesitis-related arthritis (ERA) Psoriatic arthritis (PsA) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) DE (Completed) BE (Completed) CZ (Completed) FR (Completed) SI (Completed) ES (Completed) SE (Prematurely Ended) SK (Completed) LT (Completed) NL (Completed) LV (Completed) GR (Completed) DK (Completed) IT (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-005157-29 | Sponsor Protocol Number: PHRR-04/PG/SPAXIM | Start Date*: 2007-04-27 | ||||||||||||||||
Sponsor Name:CHRU-TOURS | ||||||||||||||||||
Full Title: EFFET DU METHOTREXATE SUR LA RELATION DOSE - EFFET DE L'INFLIXIMAB DANS LA SPONDYLARTHRITE ANKYLOSANTE | ||||||||||||||||||
Medical condition: Les patients seront traités par infliximab, avec ou sans méthotrexate associé, selon la pratique habituelle en accord avec le libellé de l’A.M.M. Seuls le nombre de prélèvements sanguins et de visi... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001438-46 | Sponsor Protocol Number: A3921104 | Start Date*: 2018-03-27 | |||||||||||
Sponsor Name:Pfizer Inc. | |||||||||||||
Full Title: EFFICACY, SAFETY AND TOLERABILITY OF TOFACITINIB FOR TREATMENT OF POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS (JIA) IN CHILDREN AND ADOLESCENT SUBJECTS | |||||||||||||
Medical condition: JUVENILE IDIOPATHIC ARTHRITIS (JIA) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) BE (Completed) DE (Completed) ES (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023802-10 | Sponsor Protocol Number: B1801023 | Start Date*: 2011-07-29 | |||||||||||
Sponsor Name:Pfizer Inc.235 East 42nd Street, New York, NY 10017 | |||||||||||||
Full Title: AN OPEN LABEL EXTENSION STUDY TO ASSESS THE LONG TERM SAFETY OF ETANERCEPT IN CHILDREN AND ADOLESCENTS WITH EXTENDED OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS, ENTHESITIS RELATED ARTHRITIS, OR P... | |||||||||||||
Medical condition: OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS, ENTHESITIS RELATED ARTHRITIS, OR PSORIATIC ARTHRITIS | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) BE (Completed) FR (Completed) LT (Completed) SK (Completed) CZ (Completed) SI (Completed) ES (Completed) DE (Completed) LV (Completed) PL (Completed) NL (Completed) Outside EU/EEA NO (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-002631-33 | Sponsor Protocol Number: CAIN457A2209 | Start Date*: 2009-01-14 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: Randomized, placebo controlled, double blind, multi-center phase II proof-of-concept study to assess the efficacy of AIN457 in patients with moderate to severe ankylosing spondylitis | |||||||||||||
Medical condition: Ankylosing Spondylitis (AS), which belongs to seronegative spondyloarthropathies (SpA). | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
